| Lincare Inc | |
| 2200 Box Elder St, Ste 121, Miles City, Montana 59301 | |
| (406) 232-6561 |
| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 2200 Box Elder St, Ste 121, Miles City, Montana 59301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 232-6561 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
People with type 2 diabetes have poorer control over their blood glucose levels when they work the night shift compared with those who work in the daytime or are unemployed, a new study finds.
Smoking plays a role in lung cancer development, and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response.
A new study performed by Boston Medical Center and faculty at the Boston University School of Medicine shows that urine drug testing can be a useful tool to treat patients with opioid use disorder in a primary care setting.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in New Orleans, US.
› Verified 8 days ago
| NPI Number | 1295814309 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2200 Box Elder St Ste 121, Miles City, MT 59301 |
| Phone Number | 406-232-6561 |
News Archive
People with type 2 diabetes have poorer control over their blood glucose levels when they work the night shift compared with those who work in the daytime or are unemployed, a new study finds.
Smoking plays a role in lung cancer development, and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response.
A new study performed by Boston Medical Center and faculty at the Boston University School of Medicine shows that urine drug testing can be a useful tool to treat patients with opioid use disorder in a primary care setting.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in New Orleans, US.
› Verified 8 days ago
News Archive
People with type 2 diabetes have poorer control over their blood glucose levels when they work the night shift compared with those who work in the daytime or are unemployed, a new study finds.
Smoking plays a role in lung cancer development, and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response.
A new study performed by Boston Medical Center and faculty at the Boston University School of Medicine shows that urine drug testing can be a useful tool to treat patients with opioid use disorder in a primary care setting.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in New Orleans, US.
› Verified 8 days ago
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2909 Wilson St, Miles City, Montana 59301 Phone: (406) 232-1321 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2200 Box Elder St, Miles City, Montana 59301 Phone: (406) 232-6561 | |
Walmart Pharmacy 10-2608 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3205 Stower St, Miles City, Montana 59301 Phone: (406) 232-7320 | |
Osco Pharmacy #0039 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 519 S Haynes Ave, Miles City, Montana 59301 Phone: (406) 232-4627 | |
Miles City Vision Clinic Pc Type: Medicare Supplier Location: 1909 Main St, Miles City, Montana 59301 Phone: (406) 234-7426 |